Research ArticleConference Proceeding - Article
Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation
Qi Chen
PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 17-22; DOI: https://doi.org/10.5731/pdajpst.2014.00962
Qi Chen
Genentech, a Member of the Roche Group; Process Virology, 1 DNA Way, Mailstop 10, South San Francisco, CA 94080
Ph.D.References
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 68, Issue 1
January/February 2014
Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation
Qi Chen
PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 17-22; DOI: 10.5731/pdajpst.2014.00962
Jump to section
- Article
- Background
- Development of a Low-pH Viral Inactivation (VI) Model and Analysis of an Outlier (Lisa Connell-Crowley, Shivanthi Chinniah, and Pete Hinckley; Amgen)
- Defining Robust Operating Ranges for Low-pH Inactivation in a mAb Platform Process for Reproducible Viral Clearance (D. Vacante, H. Shen, and T. Cheung; Development, Janssen Pharmaceuticals)
- Virus Inactivation at Low pH (S. Kobayashi, Chugai Pharmaceuticals)
- Low pH Viral Inactivation: We're Not Done Yet (Daniel M. Strauss and Dayue Chen, Eli Lilly and Company)
- Summary
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.